Thyroid

Latest News

Safety and Efficacy of DOACs vs Warfarin for Patients With AFib, Hyperthyroidism

By

Amit Akirov, MD

Direct oral anticoagulants are an effective and safe alternative to warfarin treatment for patients with nonvalvular atrial fibrillation and hyperthyroidism.

Mineral and Hormonal Dysfunction Associated With Lower BMD in Thalassemia Major

By

Morgan E. Meissner

Hypothyroidism, hyperglycemia, and low adrenocorticotrophic hormone levels are associated with lower bone mass in patients with thalassemia major.

First Treatment for Thyroid Eye Disease Receives FDA Approval

By

Brian Park, PharmD

Tepezza™, an insulin-like growth factor-1 receptor inhibitor, is expected to be available in the coming weeks.

Radioiodine for Hyperthyroidism Not Found to Be Associated With Incident Cancer Risk

By

Hannah Dellabella

In patients with hyperthyroidism, treatment with radioiodine is not associated with incident cancer in long-term follow-up.

Levothyroxine Dose at Discontinuation Linked to Congenital Hypothyroidism Permanence

By

Hannah Dellabella

Compared with patients with transient congenital hypothyroidism, patients with permanent disease were on a higher levothyroxine dose at discontinuation.

Hypothyroidism: A Clinical Case Review

By

Valerie West, PA-C

Michael W. Feltz, MD

In the case of hypothyroidism, Hashimoto thyroiditis is the most common autoimmune presentation.

Trends in Incidence of Thyroid Cancer Examined in United States

From 2009 to 2016, the incidence of thyroid cancer reached a plateau and possibly started to decline.

Inflammation Linked to Thyroid Dysfunction in Patients With Psoriasis

While the rate of thyroid dysfunction among patients with psoriasis generally is not higher than expected, psoriasis in patients with thyroid dysfunction is more clinically severe and serum levels of C-reactive protein are higher.

Maternal SCH May Increase Risk for Prematurity, Neonatal Respiratory Distress

By

Hannah Dellabella

Maternal TSH levels >4 mIU/L are associated with increased risks for prematurity and neonatal respiratory distress syndrome.

Overt Hypothyroidism May Increase All-Cause Mortality Risk in Elderly Patients

Hypothyroidism is significantly associated with increased all-cause mortality, but not cardiovascular mortality, among the elderly.

FDA Panel Votes on Teprotumumab for Thyroid Eye Disease

By

Diana Ernst, RPh

The Food and Drug Administration (FDA)’s Dermatologic and Ophthalmic Drugs Advisory Committee voted in favor of the approval of teprotumumab (Horizon Therapeutics) for the treatment of thyroid eye disease.